Sigma (ASX:SIG) share price unmoved by new CEO appointment

The company has completed its search…

The Sigma Healthcare Ltd (ASX: SIG) share price is flat on Friday morning and trading at 60 cents a pop.

This comes after the pharmacy chain operator and distributor announced a leadership reshuffle for the top job.

A senior pharmacist talks to a customer at the counter in a shop.

Image source: Getty Images

Sigma appoints new CEO

In today's statement, Sigma advised that its board has appointed Vikesh Ramsunder as the new managing director and CEO.

Ramsunder brings a wealth of experience to the role, having been involved with wholesaling, logistics, pharmacy and retail sectors. He is currently serving as group CEO of Clicks Group Ltd (JSE: CLS), a position he has held since January 2019.

Clicks Group, based in South Africa, is one of the largest wholesale, pharmacy and retail operations in the African healthcare market. The company boasts over 840 stores through market-leading retail brands such as GNC, The Body Shop and Claire's. The group also has more than 600 in-store pharmacies across southern Africa.

Prior to becoming group CEO, Ramsunder held several other roles within the Clicks Group, including chief operating officer from 2015. In addition, he also took over as managing director of United Pharmaceutical Distributors (UPD), the Click Group's pharmaceutical wholesaler business.

His appointment follows an extensive search that resulted in a strong list of candidates, both internal and external.

Ramsunder is expected to commence with Sigma in February 2022 following the completion of his notice period.

Outgoing Sigma CEO and managing director, Mark Hooper will remain in the role until 31 January 2022.

Sigma chair, Ray Gunston commented:

The last four years have been committed to a sustained period of critical investments to rebuild our infrastructure in our core wholesale and retail business and set the business up for the future.

We now emerge from that phase poised to accelerate our growth. Vikesh brings the mix of skills and experience that will be valuable in leading Sigma to fast-track that growth agenda both organically and through acquisitions.

About the Sigma share price

Over the past 12 months, Sigma shares have traversed mostly sideways, with a few hiccups along the way. The Sigma share price is up by just 5.26% over the period. It is down 3.23% year to date.

Based on today's share price, Sigma has a market capitalisation of roughly $635 million. There are more than 1 billion shares outstanding.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a remarkably positive end to the trading week.

Read more »

Two miners standing together.
Broker Notes

3 ASX 200 mining shares to buy with 41% to 79% upside ahead: broker

The green energy transition and other factors are providing strong growth drivers for mining.

Read more »

Happy miner with his arms folded.
Broker Notes

Buy, hold, sell: Paladin Energy, Fortescue, Rio Tinto shares

Let's take a look at some new ratings from Morgans.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

9 ASX 200 shares experts are backing for growth amid market weakness

Brokers retained a positive view on BHP, CSL, Telstra, Xero, and other shares this week. 

Read more »

One large yellow sphere on one side of a white seesaw, with a small yellow sphere on the other side.
Opinions

I investigated 3 ASX shares that have fallen sharply. Are they bargains or value traps?

I've given my verdict on three depressed high-profile stocks.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

This ASX biotech could rise 40% or 750%, depending on who you ask

A poor quarter has reduced expectations, but there's still plenty of upside.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Opinions

These are the best 3 ASX growth shares I own and I'd buy more of today

I’m bullish about the earnings potential of these three ASX growth shares.

Read more »

Man using his device in an airport.
Broker Notes

This high-quality ASX 200 share could rise 60%

A leading broker expects a good yield and major upside from this stock.

Read more »